# Nonclinical Testing of Orally Inhaled Nicotine-Containing Drug Products Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/nonclinical-testing-of-orally-inhaled-nicotine-containing-drug-products-guidance-for-industry/0ffdae5e-74df-4de2-b513-31064caf444d

> FDA guidance document: Nonclinical Testing of Orally Inhaled Nicotine-Containing Drug Products Guidance for Industry. Issue date: October 28, 2020. Get complete insights and analysis.

---

## Details

- Title: Nonclinical Testing of Orally Inhaled Nicotine-Containing Drug Products Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2020-10-28
- Last Changed: 2020-10-28
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2018-D-2583">FDA-2018-D-2583</a>

## Related Documents

- [Safety Testing of Drug Metabolites](https://www.globalkeysolutions.net/guidances/guidance-document/safety-testing-of-drug-metabolites/f87f3786-685f-4a28-963e-3499543cdd61)
- [Osteoporosis:  Nonclinical Evaluation of Drugs Intended for Treatment Guidance for Industry:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/osteoporosis-nonclinical-evaluation-of-drugs-intended-for-treatment-guidance-for-industry-guidance-for-industry/8305ef9e-7edf-412b-bb46-28ef3a7f9493)
- [Community-Acquired Bacterial Pneumonia:  Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/community-acquired-bacterial-pneumonia-developing-drugs-for-treatment/377d93dd-9e6b-491f-92e9-51b07893cc2b)